Search

everythinglearnresearchcommunity

for

Search:↓

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

PRP treatment helps hair growth and reduces hair loss in women, but more research needed.

Microneedling with PRP and minoxidil (5%) improves hair growth more than minoxidil (5%) alone.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Anorexia and bulimia lead to serious health problems and increased risk of death, requiring aggressive treatment.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Eating disorders like anorexia and bulimia cause skin problems, and dermatologists can help detect these disorders early for better treatment outcomes.

Children, especially teenagers, can get severe SARS-CoV infection with symptoms similar to adults, but they typically recover well with supportive care.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Alopecia areata treatment varies, with no optimal method established yet.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

No cure for female pattern hair loss, but various effective treatments exist.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.